Went back and read through some of the recent announcements and saw the endometriosis POC was mentioned as due in the Sept quarter.
I know it's still bit early but seems to coincide? It's too early for Jannsen outcome and all other PromarkerD commercialization announcements didn't require a trading halt, so it has to be something relating to a discovery or fundamental change in the company.
Source: ASX Release30 July 2019
Could this be it?
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.005(0.46%) |
Mkt cap ! $142.6M | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.08 | $71.40K | 65.47K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7000 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 3000 | 1 |
View Market Depth
| Last trade - 15.20pm 25/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.10 |
Change
0.005 ( 0.92 %) |
||||
| Open | High | Low | Volume | ||
| $1.12 | $1.12 | $1.09 | 16040 | ||
| Last updated 15.57pm 25/04/2024 ? | |||||
| PIQ (ASX) Chart |